Bladder cancer Doctors Abroad — Page 7

Dr. Kittinut Kijvikai specializes in robotic-assisted surgery for bladder cancer at Bumrungrad International Hospital, with research-backed expertise.

• Expert in robotic da Vinci prostatectomy and bladder cancer procedures
• Published research on neoadjuvant therapy's impact on prostate cancer outcomes
• Contributed to studies on robotic cystectomy benefits for bladder cancer
• Focuses on improving surgical outcomes through advanced techniques

Dr. Dong Hyeon Lee is a hematologist-oncologist with of experience, specializing in bladder cancer at Ewha Womans University Medical Center.

• Expertise in treating colon cancer, hematological oncology, myelomas, and lymphoma
• Member of multiple prestigious medical societies and associations
• Published multiple research papers in oncology
• Performs bone marrow transplants, including alternate donor and mismatched transplants

Michael Van Kampen is a dedicated radiotherapy specialist with extensive experience in treating urological cancers like bladder cancer.

• Years of focused clinical practice in radiation oncology
• Applies targeted radiotherapy techniques to treat cancerous cells
• Works at the specialized Nordwest Clinic in Frankfurt
• Part of a multidisciplinary team for comprehensive cancer care

Prof. Dr. Eduard Becht brings of urology experience and an honorary doctorate to his work at Nordwest Clinic. His expertise spans from minimally invasive treatments to complex organ-preserving surgeries.

• Specializes in uro-oncology and reconstructive urology
• Awarded honorary doctorate from Kapodiastrias University of Athens
• Chairman of Interdisciplinary Urooncology Frankfurt association
• Published over 100 scientific papers on urological conditions
• Lecturer at Goethe University in Frankfurt since 1994

Prof. Dr. Ali Aydın Yavuz is a radiation oncology professor. He graduated from Hacettepe University Faculty of Medicine in 1989. He completed his specialty training in radiation oncology in 1996. He led the Department of Radiation Oncology at Karadeniz Technical University from 1997 to 2006. He served as an associate professor at Karadeniz Technical University and Başkent University from 2004 to 2009. He was Head of Radiation Oncology at Başkent University. He also served as Chief Physician of Başkent University Adana Kışla Campus for three years. He became a professor at Akdeniz University Faculty of Medicine in 2009 and remained on the faculty until 2018.

Internationally, he delivered Turkey’s first oral presentations at ASCO in 1999 and at ASTRO in 2000. In 2008 he gained experience at MD Anderson Cancer Center. He has authored many international publications. He now practices at Koru Ankara Hospital. His clinical focus includes lung, head and neck, brain, breast, gastrointestinal, urologic, gynecologic, skin, and soft tissue tumors.

Abdullah Sakin leads the Medical Oncology Department at Medipol Bahçelievler Hospital, specializing in bladder cancer treatment.

• Head of Medical Oncology at Yüzüncü Yıl University
• Trained at İstanbul Okmeydanı Training and Research Hospital
• Over a decade of experience in oncology
• Specializes in medical oncology with a focus on bladder cancer
• Worked at several prestigious hospitals in Turkey

140+ published papers on urological cancers – Dr. Mellado Gonzalez leads bladder cancer research at Hospital Clínic de Barcelona.

• Specializes in urological cancers including bladder, prostate, and kidney
• Principal investigator for multiple clinical trials on new bladder cancer therapies
• Associate Professor at University of Barcelona's Faculty of Medicine
• Post-doctoral training at Memorial Sloan-Kettering Cancer Center in New York

Dr. Sadir Alrawi is a board-certified surgical oncologist. He specializes in upper gastrointestinal, head and neck, minimally invasive, breast, and colorectal cancers. He also has expertise in heated chemoperfusion. Dr. Alrawi serves as the Director of Oncology Services at VPS Hospital system in the UAE and MENA region. He oversees several tertiary referral cancer centers.

Dr. Alrawi holds both American and British board certifications. He completed fellowships at Roswell Park Cancer Institute. He has previously led oncology divisions at Al Zahra Hospital, Tawam Hospital (a Johns Hopkins affiliate), and 21st Century Oncology in Florida. Dr. Alrawi has published widely and given many invited talks. He remains active in oncology research and education.